Concepedia

Caroline Peyrode

CP

Statistics

Publications

8

Citations

158

H-Index

8

Active since

2011

Affiliations

Inserm(Current)

Université Clermont Auvergne

Imagerie Moléculaire et Stratégies Théranostiques

Clermont Université

Centre Jean Perrin

Caroline Peyrode is an author at Inserm specializing in oncology, quaternary ammonium compounds, and tumor-activated prodrugs.

ORCID

Publications per year

2011–2020

8

Publications

8

Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing

Aurélien Voissière, E. Jouberton, Elise Maubert et al. · PLoS ONE · 2017 · 50 citations · Full text

, , +11

Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies

Caroline Peyrode, Valérie Weber, Emmanuelle David et al. · Investigational New Drugs · 2011 · 22 citations

, , +16

Small rigid platforms functionalization with quaternary ammonium: Targeting extracellular matrix of chondrosarcoma

Elisabeth Miot-Noirault, Aurélien Vidal, Jessica Morlieras et al. · Nanomedicine Nanotechnology Biology and Medicine · 2014 · 21 citations

, , +15

Structure-activity relationship study of hypoxia-activated prodrugs for proteoglycan-targeted chemotherapy in chondrosarcoma

Donia Ghedira, Aurélien Voissière, Caroline Peyrode et al. · European Journal of Medicinal Chemistry · 2018 · 17 citations · Full text

, , +15

Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept

Aurélien Voissière, Valérie Weber, Yvain Gérard et al. · Oncotarget · 2017 · 14 citations · Full text

, , +16

1–5 of 8